Dadneo

Dadneo is a Santiago-based early-stage Chilean fund and accelerator that promotes investment culture and innovation in Chile, operating at pre-seed and seed with checks below $250k. AI is not flagged as a primary focus, and healthcare interest spans digital health and consumer wellness within a broader technology mandate. The fund occupies a credible position in Chile’s relatively underbuilt early-stage venture ecosystem, where the dominant players are Corfu programs, university-affiliated funds, and a handful of private VCs. The right founder for Dadneo is a Chilean operator, often first-time founders or experienced operators on a second venture, building a digital health, telehealth, wellness, or healthcare software business with credible Chilean-market wedge and realistic regional expansion logic into Peru, Colombia, or wider Spanish-LatAm markets. The wrong founder is a deep medtech or therapeutics team, a US-modeled SaaS company without Chilean market understanding, or a Series A-ready company looking for an institutional lead. Intro paths run through Santiago’s tight venture community including Magma Partners, Manutara Ventures, ChileGlobal Ventures, and the Start-Up Chile alumni network, through Corfu and Universidad Catolica innovation networks, and through frequent co-investors and angels in the Chilean operator community. Direct outreach is read but warm intros from prior portfolio founders or accelerator alumni materially help. In the pitch, lead with the founding team’s depth, the unit economics in CLP with realistic CAC assumptions, and a credible regional expansion story since Chile alone is a small healthcare market. Be specific about ISP regulatory posture, Superintendencia de Salud rules, and the FONASA-Isapre payer dynamic that shapes private health spending in Chile. Show that you understand the difference between Santiago’s middle-class consumer market and the broader Chilean reality. Caveats include the small check size which means Dadneo is rarely a sole lead, the limited follow-on syndicate depth at Series A in Chile, and the reality that many Chilean healthcare startups eventually need to expand to larger Spanish-LatAm markets to reach Series B economics. The fit is reasonable for early-stage Chilean healthcare operators looking for first institutional capital with a local accelerator structure.